MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Assessment of Quality of Life in Patients with Hemifacial Spasm: Preliminary Report of a Case-Control Study

    N. Durmaz Celik, N. Garipcin, E. Tatlı, M. Kuzu Kumcu, S. Ozkan (Eskisehir, Turkey)

  • Assessment of the Applicability of the King and PD-PCS Scales in Patients with Parkinson’s Disease and Chronic Pain: a Pilot Study

    J. Queiroz, P. Matos, A. Ferreira Gomes, I. Santos, F. Rolim, D. de Andrade, F. Carvalho (Fortaleza, Brazil)

  • Assessment of the Impact of Environmental Factors on Disease Progression in Parkinson’s Disease

    E. Krause, L. Kovalchick, A. Medhus, J. Theo, C. Truong, S. Park, X. Zhang, W. Perkison, T. Krause (Austin, USA)

  • Assessment of the impact of the diabetic features hyperglycemia and insulin resistance on fibril induced synucleinopathy

    S. Nelson, G. Barajas, A. Cole-Strauss, M. Kubik, C. Kemp, C. Sortwell, J. Patterson (Grand Rapids, USA)

  • Association Analysis Between Genotypes and Disease Progression in Parkinson’s Disease

    ZY. Qi, YM. Sun, J. Wang (Shanghai, China)

  • Association between cognitive adverse effects of anticholinergic medication and development of long-term dementia in Parkinson’s disease

    SH. Ha, BR. Jin, SY. Kim, SM. Lee, JH. Shin, HJ. Kim (Seoul, Republic of Korea)

  • Association between corneal sensitivity with vision-related quality of life and ocular surface symptoms in Parkinson’s disease

    A. Camacho-Ordonez, M. Navarrete-Azuara, GR. Vera-Duarte, M. Rodriguez-Violante, A. Cervantes-Arriaga, AG. Alcocer-Salas, A. Ramirez-Miranda, EO. Graue-Hernandez (Mexico, Mexico)

  • Association Between Depression and Sleep Disorders in Parkinson’s Disease

    J. Jiang, W. Wu, M. Mao (Suzhou, China)

  • Association between Freezing of Gait and Probable Sarcopenia in Patients with Parkinson’s Disease

    AP. Loureiro, K. Santos, J. Souza (Curitiba, Brazil)

  • Association Between Heterozygous Loss-of-Function Variants in the MCOLN1 Gene and α-Synucleinopathies

    CX. Ying, XH. Chen, ZD. Cen, W. Luo (Hangzhou, China)

  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley